Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Noise Health ; 26(122): 287-293, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39345066

RESUMO

OBJECTIVE: This study aimed to explore the mechanism by which noise contributes to the development of Alzheimer's disease (AD)-like lesions. METHOD: Male Wistar rats (24 months) were allocated into two groups (n = 6 per groups): a noise group exposed to 98 dB sound pressure-level white noise for 4 hours daily from 8:00 to 12:00 for 30 days, and a control group without noise exposure. The cognitive functions of the rats were assessed using new-object recognition and Morris water maze tests. Then, hippocampal tissues were collected, and the levels of amyloid ß 1-42 (Aß1-42), Aß1-40, brain-derived neurotrophic factor (BDNF), and tropomyosin receptor kinase B (TrkB) were measured using enzyme-linked immunosorbent assay (ELISA). Protein expression was evaluated through Western blot. RESULTS: Noise exposure significantly impaired cognitive and recognition abilities, increased the escape latency, and decreased the number of crossings through the platform quadrant intersection and the time spent in the target quadrant (P < 0.01). The new-object exploration and recognition index of the rats in the noise group markedly decreased (P < 0.01). ELISA results indicated increases in Aß1-40 and Aß1-42 levels and decreases in BDNF and TrkB levels in the rat hippocampus in the noise group (P < 0.01). Western blot analyses revealed that beta-site amyloid precursor protein (APP) cleaving enzyme 1, phosphorylated tau protein, gamma-H2A histone family, member X, checkpoint kinase 2, p53, and p21 were remarkably elevated in the noise group (P < 0.01). CONCLUSION: Chronic noise exposure can cause hippocampal genetic damage in aged rats, leading to cognitive disorders and the development of lesions similar to those observed in AD. Thus, noise is a potential risk factor for neurodegenerative disorders.


Assuntos
Doença de Alzheimer , Peptídeos beta-Amiloides , Fator Neurotrófico Derivado do Encéfalo , Dano ao DNA , Hipocampo , Ruído , Ratos Wistar , Animais , Doença de Alzheimer/etiologia , Masculino , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Ruído/efeitos adversos , Peptídeos beta-Amiloides/metabolismo , Ratos , Hipocampo/metabolismo , Hipocampo/patologia , Fragmentos de Peptídeos/metabolismo , Receptor trkB/metabolismo , Modelos Animais de Doenças , Aprendizagem em Labirinto/fisiologia
2.
Comput Math Methods Med ; 2022: 1077980, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36213578

RESUMO

In this study, we performed a meta-analysis to investigate the anesthesia effects of remifentanil plus dexmedetomidine versus remifentanil alone in cardiac surgery. Literature search was performed on PubMed, Web of Science, Embase, China Knowledge Infrastructure, Wanfang Data, and other databases for relevant literature published in English or Chinese before October 2021. A total of 17 studies, consisting of 1350 patients, were included in this study. Of these, 10 studies showed that remifentanil plus dexmedetomidine had a good anesthesia effect in cardiac surgery (OR = 3.61, 95% CI: 1.73, 7.52, P < 0.001), and 8 studies showed that the Ramsay score test of anesthesia (SMD = 0.88; 95% CI: -0.77, 2.53; P < 0.001) in the experimental group was better than that in the control group. In addition, changes in the hemodynamic heart rate (SMD = -0.74; 95% CI: -1.41, -0.07; P < 0.001) and mean arterial pressure (SMD = -0.18; 95% CI: -0.72, 0.36; P < 0.001) of the two groups of anesthesia were counted in 17 studies, which also showed that the anesthesia effect of remifentanil plus dexmedetomidine was good. Thus, remifentanil plus dexmedetomidine may be a more promising option for cardiac surgery anesthesia than remifentanil alone.


Assuntos
Anestésicos , Procedimentos Cirúrgicos Cardíacos , Dexmedetomidina , Dexmedetomidina/farmacologia , Humanos , Piperidinas/farmacologia , Remifentanil
3.
Yi Chuan ; 30(5): 649-54, 2008 May.
Artigo em Zh | MEDLINE | ID: mdl-18487157

RESUMO

The signal peptide-encoding sequence, which was included in the gene (GenBank No. DQ782954) encoding for endoglucanase, was removed by PCR. The gene without the signal peptide was then ligated with the expression plasmid pHIS1525. The recombination plasmid pHIS1525 was transformed into Escherichia coli DH5a and the transformant was designated DH5a-pHIS1525-G7. The plasmid from the recombinant DH5a-pHIS1525-G7 was transformed into the proto-plasts of Bacillus megaterium strains WH320, and the genetically engineered bacterium, known as WH320-pHIS1525-G7, was acquired. The effective expression of the gene in the recombinant was confirmed by Congo-red dyeing and SDS poly-acrylamide gel electrophoresis (SDS-PAGE). WH320-pHIS1525-G7 was cultured in optimum condition. The activity of the endoglucanase was 899U, which was 11.22-fold higher than that of B.subtilis C-36. The properties of enzyme were deter-mined. The optimum temperature and pH value were 65 and pH 6.0, respectively. The enzyme maintained over 80% of the original enzyme activity between pH 4.5 and pH 10.0 after incubated at 50 for 30 min.


Assuntos
Bacillus megaterium/enzimologia , Bacillus megaterium/genética , Celulase/genética , Celulase/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Eletroforese em Gel de Poliacrilamida , Plasmídeos/genética , Reação em Cadeia da Polimerase , Temperatura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA